Dr. Anurag Maheshwari, MD

Dr. Maheshwari practices at TidalHealth Peninsula Regional in Salisbury, Maryland, part of TidalHealth Peninsula Regional.

Dr. Maheshwari's NPI, 1700847860, was assigned on March 29, 2006. Dr. Maheshwari holds Maryland license D53910.

Dr. Maheshwari's primary practice is TidalHealth Peninsula Regional, at 100 East Carroll Avenue, Salisbury, MD 21801 in Wicomico County. The practice phone is (410) 546-6400.

Dr. Maheshwari's primary practice is TidalHealth Peninsula Regional in Salisbury, Maryland, part of TidalHealth Peninsula Regional. Dr. Maheshwari is also affiliated with University of Maryland Shore Medical Center at Easton. The medical group on file is Mercy Personal Physicians Downtown. Dmand AI also links Dr. Maheshwari to 3 more hospitals and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maheshwari practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Maheshwari's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Maheshwari is licensed in Maryland.

CMS data shows 2,092 Medicare services from Dr. Maheshwari across 20 procedure codes in 2024, for 914 Medicare patients. Medicare paid $182,451 for them.

CMS counts 914 Medicare patients who saw Dr. Maheshwari in 2024. The largest group is 65 to 74, with 491 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maheshwari's median patient age at 67, with 55% women.

In 2024, Dr. Maheshwari wrote 2,423 Medicare Part D claims for 429 patients. 84% of them were for generic drugs. CMS names the drug for 2,105 of them, across 42 drugs with 11 or more claims each, at $1,646,646 in total drug cost. In 2023, CMS named 1,938 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Maheshwari for performance year 2024, reported as part of a group. Dr. Maheshwari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maheshwari as offering telehealth. CMS counts 162 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Maheshwari, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Maheshwari, published from 2011 to 2022. 2020 was the busiest year, with 4. The most frequent topics are Central Nervous System, Colorectal Neoplasms and Cuprizone. Dr. Maheshwari has published most often in Dig Dis Sci. Dr. Maheshwari's most frequent co-authors are Paul J. Thuluvath, MD, Amol Agarwal, MD and Joseph Alukal, MD.

Dmand AI links Dr. Maheshwari to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Non-alcoholic Fatty Liver Disease and Fatty Liver.

CMS Open Payments shows 1,740 general payments to Dr. Maheshwari from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Abbvie Inc. paid the most, $360,609. It also lists 2 research payments totaling $121 in 2022.